Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173

Jieun Seo; Jung Ah Kang; Dong In Suh; Eun Byeol Park; Cho Rong Lee; Sun Ah Choi; Soo Yeon Kim; Yeji Kim; Sang Heon Park; Michael Ye; Soon Hak Kwon; June Dong Park; Byung Chan Lim; Dong Hun Lee; Suk Jo Kang; Murim Choi; Sung Gyoo Park; Jong Hee Chae

doi:10.1016/j.jaci.2016.10.030

Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173

Jieun Seo, Jung Ah Kang, Dong In Suh, Eun Byeol Park, Cho Rong Lee, Sun Ah Choi, Soo Yeon Kim, Yeji Kim, Sang Heon Park, Michael Ye, Soon Hak Kwon, June Dong Park, Byung Chan Lim, Dong Hun Lee, Suk Jo Kang, Murim Choi, Sung Gyoo Park, Jong Hee Chae

Department of Medicine

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Original language	English
Pages (from-to)	1396-1399.e12
Journal	Journal of Allergy and Clinical Immunology
Volume	139
Issue number	4
DOIs	https://doi.org/10.1016/j.jaci.2016.10.030
State	Published - 1 Apr 2017

Access to Document

10.1016/j.jaci.2016.10.030

Cite this

Seo, J., Kang, J. A., Suh, D. I., Park, E. B., Lee, C. R., Choi, S. A., Kim, S. Y., Kim, Y., Park, S. H., Ye, M., Kwon, S. H., Park, J. D., Lim, B. C., Lee, D. H., Kang, S. J., Choi, M., Park, S. G., & Chae, J. H. (2017). Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173. Journal of Allergy and Clinical Immunology, 139(4), 1396-1399.e12. https://doi.org/10.1016/j.jaci.2016.10.030

@article{2d0c8b79b4ca4173a76604f0d48d0376,

title = "Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173",

author = "Jieun Seo and Kang, {Jung Ah} and Suh, {Dong In} and Park, {Eun Byeol} and Lee, {Cho Rong} and Choi, {Sun Ah} and Kim, {Soo Yeon} and Yeji Kim and Park, {Sang Heon} and Michael Ye and Kwon, {Soon Hak} and Park, {June Dong} and Lim, {Byung Chan} and Lee, {Dong Hun} and Kang, {Suk Jo} and Murim Choi and Park, {Sung Gyoo} and Chae, {Jong Hee}",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.jaci.2016.10.030",

language = "English",

volume = "139",

pages = "1396--1399.e12",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "4",

}

Seo, J, Kang, JA, Suh, DI, Park, EB, Lee, CR, Choi, SA, Kim, SY, Kim, Y, Park, SH, Ye, M, Kwon, SH, Park, JD, Lim, BC, Lee, DH, Kang, SJ, Choi, M, Park, SG & Chae, JH 2017, 'Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173', Journal of Allergy and Clinical Immunology, vol. 139, no. 4, pp. 1396-1399.e12. https://doi.org/10.1016/j.jaci.2016.10.030

Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173. / Seo, Jieun; Kang, Jung Ah; Suh, Dong In et al.
In: Journal of Allergy and Clinical Immunology, Vol. 139, No. 4, 01.04.2017, p. 1396-1399.e12.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173

AU - Seo, Jieun

AU - Kang, Jung Ah

AU - Suh, Dong In

AU - Park, Eun Byeol

AU - Lee, Cho Rong

AU - Choi, Sun Ah

AU - Kim, Soo Yeon

AU - Kim, Yeji

AU - Park, Sang Heon

AU - Ye, Michael

AU - Kwon, Soon Hak

AU - Park, June Dong

AU - Lim, Byung Chan

AU - Lee, Dong Hun

AU - Kang, Suk Jo

AU - Choi, Murim

AU - Park, Sung Gyoo

AU - Chae, Jong Hee

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85009471454&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2016.10.030

DO - 10.1016/j.jaci.2016.10.030

M3 - Article

C2 - 28041677

AN - SCOPUS:85009471454

SN - 0091-6749

VL - 139

SP - 1396-1399.e12

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 4

ER -

Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173

Access to Document

Other files and links

Cite this